Indrayani Biotech Ltd Q1 FY2023 consolidated PAT at Rs. 1.78 crore

INDRAYANI BIOTECH LTD. has reported Consolidated financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 26.0261 crores during the period ended June 30, 2022 as compared to Rs. 17.2521 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 1.7891 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 1.6089 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 0.52 for the period ended June 30, 2022 as compared to Rs. 0.47 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 26.0261 crs	₹17.2521 crs	50.86%
Net Profit	₹1.7891 crs	₹1.6089 crs	11.20%
EPS	₹0.52	₹0.47	10.64%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 26.0261 crores during the period ended June 30, 2022 as compared to Rs.14.3378 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.1.7891 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.0.6451 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.0.52 for the period ended June 30, 2022 as compared to Rs.0.20 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 26.0261 crs	₹14.3378 crs	81.52%
Net Profit	₹1.7891 crs	₹0.6451 crs	177.34%
EPS	₹0.52	₹0.20	160.00%

Shares of INDRAYANI BIOTECH LTD. was last trading in BSE at Rs. 60.20 as compared to the previous close of Rs. 60.50. The total number of shares traded during the day was 35001 in over 294 trades.

The stock hit an intraday high of Rs. 62.00 and intraday low of 59.05. The net turnover during the day was Rs. 2128087.00.

Source : Equity Bulls

Keywords

IndrayaniBiotech Q1FY23 ResultUpdate